tiprankstipranks
Trending News
More News >
Kiniksa Pharmaceuticals (KNSA)
NASDAQ:KNSA
US Market

Kiniksa Pharmaceuticals (KNSA) Cash flow

Compare
543 Followers

Kiniksa Pharmaceuticals Cash Flow

KNSA's free cash flow for Q3 2025 was $33.01M. For the 2025 fiscal year, KNSA's free cash flow was decreased by $12.24M and operating cash flow was $33.68M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ 25.69M$ 13.30M$ 5.81M$ -126.30M$ -136.53M
Investing Cash Flow
$ 37.67M$ -29.56M$ -8.08M$ 128.63M$ -23.44M
Financing Cash Flow
$ 12.27M$ 1.50M$ 2.52M$ 5.88M$ 227.09M
End Cash Position
$ 183.58M$ 107.95M$ 122.72M$ 122.47M$ 114.25M
Free Cash Flow
$ 25.41M$ 13.17M$ 5.70M$ -146.71M$ -136.81M
Currency in USD

Kiniksa Pharmaceuticals Cash Flow